Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Meijer

Showing results (271-280 of 282) with videos related to

Pageof 29
Sort By:
Science Advances|October 13, 2016
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancerEmily K Law, Anieta M Sieuwerts, Kelly LaPara, et al.
Cancer Research|May 19, 2005
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancerJohn W M Martens, Inko Nimmrich, Thomas Koenig, et al.
Breast Cancer Research and Treatment|October 30, 2007
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patientsInko Nimmrich, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.
Pharmacogenomics|August 12, 2011
The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patientsRon H N van Schaik, Marleen Kok, Fred C G J Sweep, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
The prognostic value of BCAR1 in patients with primary breast cancerLambert C J Dorssers, Nicolai Grebenchtchikov, Arend Brinkman, et al.
Leukemia|April 28, 2016
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working PartyM Sobh, M Michallet, G Gahrton, et al.
Plos One|November 16, 2016
Correction: Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial InfarctionMaurits R Hollander, Guus A de Waard, Lara S F Konijnenberg, et al.
Plos One|July 9, 2016
Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial InfarctionMaurits R Hollander, Guus A de Waard, Lara S F Konijnenberg, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 9, 2023
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effectsSuzy E Meijer, Ora Halutz, Amos Adler, et al.
Journal of the National Cancer Institute|January 17, 2002
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patientsMaxime P Look, Wim L J van Putten, Michael J Duffy, et al.
Pageof 29

Showing results (271-280 of 282) with videos related to

Sort By:
Pageof 29
Science Advances|October 13, 2016
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancerEmily K Law, Anieta M Sieuwerts, Kelly LaPara, et al.
Cancer Research|May 19, 2005
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancerJohn W M Martens, Inko Nimmrich, Thomas Koenig, et al.
Breast Cancer Research and Treatment|October 30, 2007
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patientsInko Nimmrich, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.
Pharmacogenomics|August 12, 2011
The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patientsRon H N van Schaik, Marleen Kok, Fred C G J Sweep, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
The prognostic value of BCAR1 in patients with primary breast cancerLambert C J Dorssers, Nicolai Grebenchtchikov, Arend Brinkman, et al.
Leukemia|April 28, 2016
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working PartyM Sobh, M Michallet, G Gahrton, et al.
Plos One|November 16, 2016
Correction: Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial InfarctionMaurits R Hollander, Guus A de Waard, Lara S F Konijnenberg, et al.
Plos One|July 9, 2016
Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial InfarctionMaurits R Hollander, Guus A de Waard, Lara S F Konijnenberg, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 9, 2023
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effectsSuzy E Meijer, Ora Halutz, Amos Adler, et al.
Journal of the National Cancer Institute|January 17, 2002
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patientsMaxime P Look, Wim L J van Putten, Michael J Duffy, et al.
Pageof 29